• Presbyopia Correction A-Z, 3rd Argos & IOLs Masterclass, Bahrain, 2026
  • Pioneer Innovations in Cataract Surgery, OMMA Congress-Latest Advances in Ophthalmology, Athens, 2025
  • The Clareon Journey, from Clarity to Completeness, Saudi Ophthalmology Conference, Riyadh 2025
  • Premium Lenses change the era for cataract surgery, SRO, Sinaia, Romania 2025
  • Presenting the benefits of an enhanced trifocal IOL for Presbyopia Management (clinical cases), Ophthaxchange Event by Alcon, Athens, Greece 2025
  • Presbyopia Patient Awareness Campaign, Sperses, Greece 2025
  • Fan Club Cataract & Refractive Surgery, 58th Panhellenic Ophthalmological Congress, Ilis Greece, 2025
  • Unsatisfactory outcome after IOL implantation: When the culprit is the Residual Refractive Error, AICCER, Trieste Italy 2025
  • Advanced Technology IOL: Novel Technologies to improve near vision, AICCER, Trieste Italy 2025
  • Correcting Presbyopia with Lens Surgery: How to do it and what are the achievable results. Let’s see clearly: which IOLs will we use in the near future?, AICCER, Trieste Italy 2025
  • Communication as key to patient satisfaction, Winter ESCRS, Athens 2025
  • Best of the Best session, IOL power calculation/IOLs, Winter ESCRS, Athens 2025
  • No one dreams about Silver-Gold medal prospectives in presbyopia correction, OMMA Congress-Latest Advances in Ophthalmology, Athens, 2024
  • No one dreams about Silver-Gold medal prospectives in presbyopia correction, Annual Congress of the Cyprus Ophthalmological Society Limassol 2024
  • Addressing barriers for incorporating Presbyopia IOL procedures into the everyday cataract Practice, ESCRS Barcelona 2024
  • More physiologic IOP Breakfast meeting, Barcelona 2024
  • Patient profile for presbyopia correcting IOLs, PC-IOL & Argos Masterclass, Barcelona, 2024
  • Present and future in presbyopia correction, Clareon PanOptix Launch Event & Astigmatism Management Education, Tallin Estonia, 2024
  • Patient Selection, PCIOL Vivity® Session, 10th EPOMEC, Dubai, 2023
  • X-Wave technology PC-IOL Vivity® Visual Performance Registry Data, See things differently and expand visual possibilities with Acrysof IQ Vivity®, 10th EPOMEC, Dubai, 2023
  • Argos Launch Event, 18th Croatian Organisation for Cataract and Refractive Surgery Symposium, Zadar, 2023
  • Cases video presentation: presbyopia and astigmatism correction, 56th Panhellenic Ophthalmological Congress, Ioannina Greece, 2023
  • Broken Posterior Capsule, the sinking nucleus and the dangling IOL: Vitrectomy by the anterior segment surgeon?, 37th HSIOIRS, Athens 2023
  • Presbyopia quiz: Do we have a solution?, OMMA Congress-Latest Advances in Ophthalmology, Athens, 2022
  • Presbyopia Correction IOLs: Pearls and Pitfalls, 12th annual Congress of Cyprus Ophthalmological Society, Lemesos, 2022
  • Converting Patients to PCIOLs, COR Group Meeting Helsinki Finland 2022
  • Presbyopia Correction IOLs: Tips and Pearls, 17th Croatian Organisation for Cataract and Refractive Surgery Symposium, Zagreb, 2022
  • Alcon Advisory Board-Next Generation PanOptix & Vivity, ASCRS, Washington DC, 2022
  • Pearls for implanting toric IOLs, Hungarian National Cataract and Refractive Congress, 2022
  • My experience with Acrysof® IQ Panoptix Trifocal IOLs – Advancing Cataract Refractive Surgery and Presbyopia Correction – Better outcomes for more patients, 26th ESCRS Winter Meeting 2022
  • Better outcomes for more patients: Our experience with new X-EDOF technology, OMMA Congress-Latest advances in Ophthalmology, 2021
  • Presbyopia correcting IOLs, 54th Panhellenic Ophthalmological Congress, 2021
  • International YO Ad-Board: The future as Ophthalmologist, Alcon, International Scientific Alliance, 2021
  • Presbyopia Correction: My Experience with Trifocal IOLs, OMMA Congress-Latest advances in Ophthalmology, 2020
  • Presbyopia Correcting IOLs: My Experience with 500 Patients, Alcon Phaco Development International Cyber Symposium, 2020
  • Expert Panel Discussion: Presbyopia and Premium IOLs, AECOS Winter Symposium, 2020
  • Modern Cataract Surgery, OMMA Congress-Latest advances in Ophthalmology, 2019
  • Clinical Outcomes of Patients with Multifocal/Multifocal Toric IOL implantation, Pan-Hellenic Ophthalmological Congress, 2019
  • Follow up results after treatment with peptide Bio-regulators in patients with genetic retinal disorders, International Symposium of Gerontology, 2019
  • New advancements in Monofocal IOL Platforms, OMMA Congress-Latest advances in Ophthalmology, 2018
  • 12 months follow-up results after PDT-LF in 25 patients with chronic central serous chorioretinopathy, 10th Mediterretina International Meeting, 2018
  • OCT-Angiography in different clinical entities through different machines, Greek Ophthalmological Society Congress, 2018
  • Clinical Application of Peptide Bioregulators in Pathological Treatment of Retinitis Pigmentosa, International Gerontology Symposium, 2018
  • OCT Angiography with Swept Source OCT in diabetic patients, presented at Greek Vitreoretinal Symposium (GVRS), 2018
  • OCT Angiography for diagnosis and follow-up of patients with PCV and CNV, presented at Greek Vitreoretinal Symposium (GVRS), 2018
  • Pre- and Postoperative tips for toric multifocal lens implantation, OMMA Congress-Latest Advances in Ophthalmology, 2017
  • Cataract Surgery: Pearls and pitfalls for the most demanding eyes, Greek College of Ophthalmologists, 2017
  • Lens anatomy and physiology, University Ophthalmological Clinic of Athens, 2017
  • Application of Peptide Bioregulators in Pathological Treatment of Retinitis Pigmentosa, International Gerontology Symposium, 2017
  • Case report of IRVAN Syndrome, OMMA Ophthalmological Meeting in Medical Retina, 2016
  • Second Generation Trifocal Intraocular Lens with ENLIGHTEN Technology. Review and Advantages, OMMA Congress-Latest advances in Ophthalmology, 2016
  • From Cataract to Diabetic Retinopathy, important advances in Diagnosis and Therapeutic treatment, IASO GENERAL HOPSITAL Meeting, 2016
  • Number of intravitreal injections in 50 patients with polypoidal choroidal vasculopathy (PCV) treated with combination of low fluence photodynamic therapy (PDT-LF) and intravitreal anti-VEGF injection, 10th Pan-Hellenic Vitreo-Retinal Meeting, 2015
  • Glaucoma, what advances will the future bring, OMMA Congress-Latest Advances in Ophthalmology, 2015
  • Optical Coherence tomography (OCT), basic principles, Scientific Vitreo-Retinal Meeting, 2014
  • How did it feel at my first cataract operation ever, National College of Ophthalmologists Meeting, 2014
  • Mystery Retina Clinical Workshop, ocular lymphoma case report, 8th Pan-Hellenic Vitreo-Retinal Meeting, 2013
  • Bevacizumab (Avastin) safety after 14000 intravitreal injections in cases of choroidal neovascularisation, diabetic retinopathy, vascular occlusions and pseudophakic oedema, 8th Pan-Hellenic Vitreo-Retinal Meeting, 2013
  • Number of intravitreal injections in 25 patients with polypoidal choroidal vasculopathy treated with combined therapy of low-fluence photodynamic therapy (PDT-LF) and intravitreal anti-VEGF injection, 8th Pan-Hellenic Vitreo-Retinal Meeting, 2013
  • 12 months follow up results after low fluence photodynamic therapy (PDT-LF) in 25 patients with chronic central serous chorioretinopathy (CSR), 7th Greek Vitreoretinal Society (GVRS) Congress, 2012
  • DRY LAB – Fluorescein angiography, HIGH SPEED ICG, OCT, UBM ultrasound, 7th Greek Vitreoretinal Society (GVRS) Congress, 2012
  • Spectral Domain OCT in glaucoma diagnosis, OMMA Congress-Latest advances in Ophthalmology, 2011
  • Dry Lab, Spectral domain OCT (Spectralis) Diagnosis and management of diabetic macular oedema, 44th Pan-Hellenic Ophthalmological Congress, 2011
  • Management of macular oedema related to AMD, 44th Pan-Hellenic Ophthalmological Congress, 2011
  • Bevacizumab (Avastin) safety after 10000 intravitreal injections in cases of choroidal neovascularisation, diabetic retinopathy, vascular occlusions and pseudophakic oedema, 6th Pan-Hellenic Vitreo-Retinal Meeting, 2011
  • Dry Lab, Fluorescein Angiography, High Speed ICG, OCT, UBM, US, 6th Pan-Hellenic Vitreo-Retinal Meeting, 2011
  • Case presentation, at the fun club of Fluorescein Angiography, 43rd Pan-Hellenic Ophthalmological Congress, 2010
  • Number of intravitreal injections in 25 patients with wet type age-related macular degeneration treated with combined therapy of low-fluence photodynamic therapy (PDT-LF) and intravitreal Ranibizumab (Lucentis) injection in a period of 12 months, 42nd Pan-Hellenic Ophthalmological Congress, 2009
  • OCT (Optical Coherence Tomography) findings in patients with age-related macular degeneration (ARMD) treated with combination of low-fluence PDT (PDT-LF) and intravitreal Lucentis injection, 42nd Pan-Hellenic Ophthalmological Congress, 2009
  • Newer therapeutic indications of Anti-VEGF, 42nd Pan-Hellenic Ophthalmological Congress, 2009
  • OCT (Optical Coherence Tomography) findings in patients with age-related macular degeneration (ARMD) treated with combination of PDT (Photodynamic Therapy) and intravitreal Pegaptanib Sodium (Macugen) injection, 41st Pan-Hellenic Ophthalmological Congress, 2008
  • Facial Nerve Palsy, Eye Clinic of Furness General ospitalHospitalHospital, 2007
  • Eye changes in degenerative myopia, Eye Clinic of Furness General ospitalHospitalHospital, 2007
  • Herpes Virus and Eye infection, Eye Clinic of Furness General ospitalHospitalHospital, 2006
  • Age related macular degeneration, Eye Clinic of Furness General ospitalHospitalHospital, 2006
  • Congenital Nasolacrimal Duct Obstruction, Eye Treatment Centre of the West Suffolk Hospital, 2006
  • Audit on cataract operations outcomes and complication rates, Furness General Hospital, Supervisor Mrs Shrimpton, 2006
  • Audit on nasolacrimal duct probing success in children, West Suffolk Hospital, supervisor Mr Vivian, 2006